Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report
Authors:
- 28 February 2020
- journal article
- review article
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 54 (2) , 91-98
Abstract
Objectives: There is confusion about the terms of bladder pain syndrome (BPS) and Interstitial Cystitis (IC). The European Society for the Study of IC (ESSIC) classified these according to objective findings [ 9 van de Merwe JP , Nordling J , Bouchelouche P , et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–67. [Crossref], [PubMed], [Web of Science ®] , [Google Scholar] ]. One phenotype, Hunner lesion disease (HLD or ESSIC 3C) differs markedly from other presentations. Therefore, the question was raised as to whether this is a separate condition or BPS subtype. Methods: An evaluation was made to explore if HLD differs from other BPS presentations regarding symptomatology, physical examination findings, laboratory tests, endoscopy, histopathology, natural history, epidemiology, prognosis and treatment outcomes. Results: Cystoscopy is the method of choice to identify Hunner lesions, histopathology the method to confirm it. You cannot distinguish between main forms of BPS by means of symptoms, physical examination or laboratory tests. Epidemiologic data are incomplete. HLD seems relatively uncommon, although more frequent in older patients than non-HLD. No indication has been presented of BPS and HLD as a continuum of conditions, one developing into the other. Conclusions: A paradigm shift in the understanding of BPS/IC is urgent. A highly topical issue is to separate HLD and BPS: treatment results and prognoses differ substantially. Since historically, IC was tantamount to Hunner lesions and interstitial inflammation in the bladder wall, still, a valid definition, the term IC should preferably be reserved for HLD patients. BPS is a symptom syndrome without specific objective findings and should be used for other patients fulfilling the ESSIC definitions.Keywords
This publication has 47 references indexed in Scilit:
- Symptom profile variability of interstitial cystitis/painful bladder syndrome by ageBJU International, 2011
- The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive BladderJSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 2010
- Quantifying mast cells in bladder pain syndrome by immunohistochemical analysisBJU International, 2008
- Urine Markers Do Not Predict Biopsy Findings or Presence of Bladder Ulcers in Interstitial Cystitis/Painful Bladder SyndromeJournal of Urology, 2008
- Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: A prospective study with cyclosporine A and pentosan polysulfate sodiumNeurourology and Urodynamics, 2006
- Primary Evaluation of Patients Suspected of Having Interstitial Cystitis (IC)European Urology, 2004
- Intravesical Nitric Oxide Production Discriminates Between Classic and Nonulcer Interstitial CystitisJournal of Urology, 2004
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- USE OF THE NEODYMIUM: YAG LASER FOR INTERSTITIAL CYSTITIS: A PROSPECTIVE STUDYJournal of Urology, 2001
- CYSTOSCOPIC FINDINGS CONSISTENT WITH INTERSTITIAL CYSTITIS IN NORMAL WOMEN UNDERGOING TUBAL LIGATIONJournal of Urology, 1998